Survival and Quality of life of Cancer Patients with incidental PE
Research type
Research Study
Full title
The SCaIPEL study: Survival and Quality of Life of Cancer Patients with Incidental Pulmonary Embolism Treated with LMWH
IRAS ID
156598
Contact name
Anthony Maraveyas
Contact email
Sponsor organisation
Hull & East Yorkshire Hospitals NHS Trust
Eudract number
2015-001707-31
Duration of Study in the UK
2 years, 6 months, 1 days
Research summary
Advances in medical technology have resulted in an increase in the detection of unexpected blood clots in the lung of patients with cancer. We are looking to see the effects these blood clots may have on the survival and quality of life of these patients, when compared to cancer patients without blood clots. We will also be performing laboratory tests to see whether certain markers carried in the blood or expressed on the tumours of these patients might be used to predict their risk of developing these clots. It is hoped that we can find a way to identify high-risk patients so we can treat them before these clots have chance to develop.
REC name
Yorkshire & The Humber - Leeds East Research Ethics Committee
REC reference
15/YH/0237
Date of REC Opinion
10 Jul 2015
REC opinion
Further Information Favourable Opinion